The attitude of modern women towards the prevention of cervical carcinoma
Abstract
: Most of the participants in our study would spend up to twenty leva (BGN) per year for cervical cancer prevention. The highest percentage of women who believe that prophylaxis should be free of charge after having health insurance is in the group of Bulgarians. Most of the respondents are ready to spend up to one day per year on prevention of cervical cancer prevention, followed by women who believe that only a few hours a year are enough. For the age group up to 25 years the highest percentage of respondents considered that they would not have to spend any time to prevent cervical cancer. In the group of the lowest educated women, compared to the other groups, there are predominantly those who think they do not have to take any time to prevent or have no opinion on the issue. The same decreases significantly in educated women with secondary and tertiary education.
Keywords
Full Text:
PDFReferences
Alvarez EA, Brady WE, Walker JL, et al. Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2013 Apr;129(1):22-7. Epub 2012 Dec 20.
Bray, F., et al., Endometrial cancer incidence trends in Europe: underlying determinants and prospects for prevention. Cancer Epidemiol Biomarkers Prev, 2005. 14(5): p. 1132-[26]Beining RM, Dennis LK, Smith EM, Dokras A. Meta-analysis of intrauterine device use and risk of endometrial cancer. Ann Epidemiol. 2008;18:492-499.
Cardenes HR, Look K, Michael H, Cerezo L. Endometrium. In: Halperin EC, Perez CA,
Brady LW, eds. Perez and Brady's Principles and Practice of Radiation Oncology. 5th ed. Philadelphia, Pa: Lippincott Williams and Wilkins; 2008: 1610-1628.
European age-standardised rates calculated by the Statistical Information Team at Cancer Research UK. 2011, using data from GLOBOCAN 2008, v1.2, IARC.
Evans JM, Donnelly LA, Emslie-Smith AM, et al. Metformin and reduced risk of cancer in diabetic patients. BMJ. 2005;330:1304–1305.
Fukuda K, Mori M, Uchiyama M, et al. Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma. Gynecol Oncol. 1998 Jun;69(3):220-5.
Galizia G, Gemei M, Orditura M, Romano C, Zamboli A, Castellano P, Lieto E. Postoperative Detection of Circulating Tumor Cells Predicts Tumor Recurrence in Colorectal Cancer Patients. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. Jun 28 2013.
Jick H, Walker AM, Rothman KJ. The epidemic of endometrial cancer: a commentary. Am J Public Health. 1980 Mar;70(3):264-7.
Nout RA, Smit VT, Putter H, et al. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. Lancet. 2010 Mar 6;375(9717):816-23.
Nussler NC, Reinbacher K, Shanny N, et al. Sex-specific differences in the expression levels of estrogen receptor subtypes in coloectal cancer. Gend Med. 2008 Sep;5(3):209-17.
Odagiri T, Watari H, Hosaka M, Mitamura T, Konno Y, Kato T, . . . Sakuragi N. Multivariate survival analysis of the patients with recurrent endometrial cancer. J Gynecol Oncol. Mar 31 2011;22(1):3-8.
Ohno S, Sumiyoshi Y, Hashine K, Shirato A, Kyo S, Inoue M. Phase I Clinical Study of the Dietary Supplement, Agaricus blazei Murill, in Cancer Patients in Remission. Evidence-based complementary and alternative medicine : eCAM. 2011;2011:192381.
Ollberding NJ, Lim U, Wilkens LR, Setiawan VW, Shvetsov YB, Henderson BE, . . . Goodman MT. Legume, soy, tofu, and isoflavone intake and endometrial cancer risk in postmenopausal women in the multiethnic cohort study. Journal of the National Cancer Institute. Jan 4 2012;104(1):67-76.
Punnonen R, Mattila J, Kuoppala T, Koivula T. DNA ploidy, cell proliferation and steroid hormone receptors in endometrial hyperplasia and early adenocarcinoma. J Cancer Res Clin Oncol. 1993;119(7):426-429.
Purdie DM, Green AC. Epidemiology of endometrial cancer. Best Pract Res Clin Obstet Gynaecol. Jun 2001;15(3):341-354.
Rahaman J and Cohen CJ. Gynecologic Sarcomas. In Kufe DW, Pollock RE, Weichselbaum RR, et al., editors. Holland-Frei Cancer Medicine. 6h Edition. Chapter 120. Hamilton (ON): BC Decker; 2003. http://www.ncbi.nlm.nih.gov/books/NBK13954/
Rahbari NN, Bork U, Kircher A, Nimitz T, Schölch S, Kahlert C, Schmidt T, Steinert G, Ulrich AB, Reissfelder C, Büchler MW, Koch M, Weitz J. Compartmental differences of circulating tumor cells in colorectal cancer.Ann Surg Oncol. 2012 Jul;19(7):2195-202.
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.